Home » Topics » BioWorld Science

BioWorld Science
RSS

RiboGene and Trega Biosciences extend drug discovery collaboration

July 17, 1997

Final dosimetry analysis of phase II/III trial of Oncolym

July 17, 1997

Kanebo reports novel cell adhesion inhibitors

July 17, 1997

Mycophenolic acid derivatives with immunosuppressive activity claimed

July 17, 1997

Preliminary results from IMpact-RSV trial

July 17, 1997

Low-dose interferon alfa nears phase III for the treatment of Sjogren's syndrome

July 17, 1997

Cell Pathways reports chemoprotective activity of sulindac sulfone in animal model

July 17, 1997

Novel antiinflammatory agents prepared by French investigators

July 17, 1997

FDA approves first medical device for epilepsy

July 17, 1997

Potent, orally active fibrinogen antagonist developed at Merck & Co.

July 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...